OP0083 ANAKINRA PLUS STANDARD OF CARE FOR THE REDUCTION OF HYPERINFLAMMATION AND RESPIRATORY DISTRESS IN PATIENTS WITH SARS-COV-2 INFECTION: A MULTICENTRE, RANDOMISED, OPEN-LABEL PHASE 2/3 TRIAL (ANA-COVID-GEAS STUDY)

Fanlo, P. ; Gracia Tello, B. ; Fonseca, E. ; Álvarez Troncoso, J. ; González, A. ; Prieto-González, S. ; Freire, M. ; Argibay, A. ; Pallares Ferreres, L. ; Todoli, J. A. ; Perez Conesa, M. ; Bujan Rivas, S. ; Ibañez, B.

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.57-58 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível